Jiangsu Hengrui | 600276 - Ebitda

Stock Price
55.38
Daily Change
-0.67 -1.20%
Monthly
-0.68%
Yearly
10.83%
Q2 Forecast
54.92

Jiangsu Hengrui reported CNY2.3B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Kangmei Pharma CNY 17.3M 20.56M Jun/2025
Sh Fosun Pharma CNY 1.69B 17.13M Jun/2025
Sh Pharmaceutical CNY 5.01B 2.41B Jun/2025
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
WuXi AppTec CNY 8.95B 3.24B Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 531.61M 658.23M Jun/2025